Pharmaceutical formulations comprins beta-2 andrenoreceptor antagonists and xanthines

摘要

A pharmaceutical formulation comprising (i) a sustained release layer comprising at least one xanthine, and (ii) an immediate release layer comprising at least one beta-2 adrenoreceptor agonist selected from the group consisting of long acting and short acting beta-2 adrenoreceptor agonists.